Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.
Boston Scientific (NYSE:BSX) announced today that it completed its previously announced acquisition of Nalu Medical.
(BU) today announced it has been awarded a $2 million research grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF).
Zacks Investment Research on MSN
CLPT gets EU MDR certification for ClearPoint navigation software
ClearPoint Neuro, Inc. CLPT, a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, recently received EU MDR Certification for its ClearPoint ...
At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.
EINDHOVEN, the Netherlands, Jan. 23, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore ...
ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore movement ...
Investigational ARC-BCI Therapy is being developed to restore thought-driven movement in people living with spinal cord injuries and other movement disabilitiesARC-BCI is the world's first and most ad ...
Good morning, and welcome to the Boston Scientific Investor Update. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Lauren Tengler, ...
Medtronic will integrate Precision Neuroscience’s Layer 7 cortical interface with its StealthStation surgical navigation ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Boston Scientific Corp. is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results